Hedy Kindler to Prostatic Neoplasms
This is a "connection" page, showing publications Hedy Kindler has written about Prostatic Neoplasms.
Connection Strength
0.007
-
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies. Clin Cancer Res. 2004 Jul 01; 10(13):4406-11.
Score: 0.007
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.